Works matching IS 15257304 AND DT 2024 AND VI 25 AND IP 6

Results: 12

MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage LIB-ILIB NSCLC.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 587, doi. 10.1016/j.cllc.2024.06.007
By:
- Reck, Martin;
- Nadal, Ernest;
- Girard, Nicolas;
- Filippi, Andrea R.;
- Martin, Linda W.;
- Gay, Carl M.;
- Petersen, Cordula;
- Gale, Davina;
- Emeribe, Ugochinyere A.;
- Georgoulia, Nefeli;
- Perez, Ignacio E. Diaz;
- Spicer, Jonathan D.
Publication type:
Article
Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 581, doi. 10.1016/j.cllc.2024.06.010
By:
- Daisuke Shibahara;
- Kentaro Tanaka;
- Osamu Togao;
- Yoshimasa Shiraishi;
- Yasuto Yoneshima;
- Eiji Iwama;
- Tadamasa Yoshitake;
- Kousei Ishigami;
- Isamu Okamoto
Publication type:
Article
Tepotinib in a Patient With Advanced Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Undergoing Concomitant Hemodialysis for Renal Failure: A Case Report.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 577, doi. 10.1016/j.cllc.2024.05.008
By:
- Kleemiss, Moritz;
- Muller, Christa E.;
- Schneider, Marion;
- Strotmann, Rainer;
- Orlowski, Katrin;
- Goteti, Kosalaram;
- Yanik, Mert;
- Brossart, Peter;
- Bauernfeind, Franz-Georg
Publication type:
Article
Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 567, doi. 10.1016/j.cllc.2024.05.001
By:
- Minne, Rachel L.;
- Luo, Natalie Y.;
- Traynor, Anne M.;
- Minxuan Huang;
- DeTullio, Luisina;
- Godden, Jen;
- Stoppler, Melissa;
- Kimple, Randall J.;
- Baschnagel, Andrew M.
Publication type:
Article
Factors Associated With Margin Positivity After Lung Resection Surgery.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 560, doi. 10.1016/j.cllc.2024.03.007
By:
- Rshaidat, Hamza;
- Whitehorn, Gregory L.;
- Collins, Micaela;
- Mack, Shale J.;
- Martin, Jonathan;
- Grenda, Tyler R.;
- Evans III, Nathaniel R.;
- Okusanya, Olugbenga T.
Publication type:
Article
Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 550, doi. 10.1016/j.cllc.2024.06.006
By:
- Shah, Arpeet T.;
- Blanchard, Isabelle;
- Padda, Sukhmani K.;
- Wakelee, Heather A.;
- Neal, Joel W.
Publication type:
Article
Surgery and Stereotactic Radiotherapy for Stage I Small-Cell Lung Carcinoma: A 25-Year Experience.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 537, doi. 10.1016/j.cllc.2024.06.001
By:
- Robinson, Lary A.;
- Tanvetyanon, Tawee;
- Robinson, Noah A.;
- Bryant, Sandra;
- Bailey, Alexis;
- Reed, Damon R.;
- Dilling, Thomas
Publication type:
Article
Prediction of Pleural Lavage Cytology According to Thin-Section Computed Tomography in Non-Small-Cell Lung Cancer.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 529, doi. 10.1016/j.cllc.2024.04.010
By:
- Yuto Nonaka;
- Mitsuhiro Isaka;
- Keigo Matsushima;
- Shinya Katsumata;
- Hayato Konno;
- Tetsuya Mizuno;
- Toshiyuki Nagata;
- Akifumi Notsu;
- Kiyoshi Tone;
- Takuya Kawata;
- Masahiro Endo;
- Yasuhisa Ohde
Publication type:
Article
Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 519, doi. 10.1016/j.cllc.2024.05.010
By:
- Tomoyuki Hishida;
- Jiro Okami;
- Hisao Asamura;
- Etsuo Miyaoka;
- Yasushi Shintani;
- Mitsutaka Kadokura;
- Shunsuke Endo;
- Masayuki Chida;
- Hidemi Suzuki;
- Ichiro Yoshino;
- Hiroshi Date
Publication type:
Article
Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 509, doi. 10.1016/j.cllc.2024.05.003
By:
- Awidi, Muhammad;
- Mier-Hicks, Angel;
- Perimbeti, Stuthi;
- Attwood, Kristopher;
- Hongbin Chen;
- Jain, Prantesh;
- Yau, Edwin;
- Early, Amy;
- Dy, Grace K.
Publication type:
Article
5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-Ll Expression 2 50% Ad vance d NSCLC.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 502, doi. 10.1016/j.cllc.2024.05.002
By:
- Velcheti, Vamsidhar;
- Rai, Pragya;
- Yu-Han Kao;
- Chirovsky, Diana;
- Nunes, Ana Tablante;
- Liu, Stephen V.
Publication type:
Article
The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases.
Published in:
Clinical Lung Cancer, 2024, v. 25, n. 6, p. 483, doi. 10.1016/j.cllc.2024.06.004
By:
- Xiancheng Wu;
- Stabile, Laura R.;
- Burns, Timothy E.
Publication type:
Article